1 Agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
61 Antibiotics
|
611 Acting mainly on gram-positive bacteria
|
612 Acting mainly on gram-negative bacteria
|
613 Acting mainly on gram-positive and gram-negative bacteria
|
614 Acting mainly on gram-positive bacteria and mycoplasma
|
6141 Erythromycins
|
D00140 Erythromycin (JP18/USP/INN)
D01361 Erythromycin ethylsuccinate (JP18/USP)
D02009 Erythromycin lactobionate (JP18/USP)
D02184 Erythromycin stearate (JP18/USP)
|
6142 Spiramycin antibiotics
|
6143 Kitasamycins
|
6144 Oleandomycins
|
6145 Josamycins
|
6146 Midecamycins
|
6149 Others
|
615 Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia
|
616 Acting mainly on acid-fast bacteria
|
617 Acting mainly on mold
|
619 Miscellaneous
|
62 Chemotherapeutics
|
63 Biological preparations
|
64 Parasitics (systemic)
|
69 Other agents against pathogenic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|